<SEC-DOCUMENT>0001415889-23-003014-index.html : 20230222
<SEC-HEADER>0001415889-23-003014.hdr.sgml : 20230222
<ACCEPTANCE-DATETIME>20230222170545
ACCESSION NUMBER:		0001415889-23-003014
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20230214
FILED AS OF DATE:		20230222
DATE AS OF CHANGE:		20230222

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Grimaud Brett A.
		CENTRAL INDEX KEY:			0001966698

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36033
		FILM NUMBER:		23654434

	MAIL ADDRESS:	
		STREET 1:		901 GATEWAY BLVD
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Theravance Biopharma, Inc.
		CENTRAL INDEX KEY:			0001583107
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		UGLAND HOUSE, SOUTH CHURCH STREET
		CITY:			GEORGE TOWN, GRAND CAYMAN
		STATE:			E9
		ZIP:			KY1-1104
		BUSINESS PHONE:		650-808-6000

	MAIL ADDRESS:	
		STREET 1:		UGLAND HOUSE, SOUTH CHURCH STREET
		CITY:			GEORGE TOWN, GRAND CAYMAN
		STATE:			E9
		ZIP:			KY1-1104
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>form3-02222023_100237.xml
<TEXT>
Document 1 - file: form3-02222023_100237.html

Document 1 - RAW XML: form3-02222023_100237.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>ex24-02222023_100238.htm
<TEXT>
Document 2 - file: ex24-02222023_100238.htm

</DOCUMENT>
</SEC-DOCUMENT>